全球一体化的临床阶段生物技术公司，专注代谢性疾病、消化系统疾病等领域的重大未满足临床需求，立足源头创新，以患者的综合临床获益和整体健康改善为目标，开发“First-in-Class”多靶点原创新药。
Total raised: $107M
Investors 1
| Date | Name | Website |
| - | Cowin Capi... | cowincapit... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.01.2023 | Series C | $107M | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 20.12.2023 | Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia... | We've launched a new Fierce Biotech Fundraising Tracker for 2023 to track all the venture capital fl... | fiercebiot... |
| 06.01.2023 | HighTide Therapeutics Raises $107M in Series C/C+ Financing | HighTide Therapeutics, a Rockville, MD-based biopharmaceutical company developing novel multifunctio... | finsmes.co... |
| 05.01.2023 | Biotech firm HighTide raises $107m in Series C, C+ rounds fr... | Global clinical-stage biotech firm HighTide Therapeutics has completed its Series C, C+ rounds of fi... | dealstreet... |
| - | HighTide Therapeutics | “HighTide” | fastfounde... |